KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Shares Repurchased (2016 - 2022)

Amgen has reported Shares Repurchased over the past 14 years, most recently at $6.4 billion for Q1 2022.

  • Quarterly results put Shares Repurchased at $6.4 billion for Q1 2022, up 630.2% from a year ago — trailing twelve months through Dec 2022 was $6.4 billion (up 27.84% YoY), and the annual figure for FY2024 was $200.0 million, changed.
  • Shares Repurchased for Q1 2022 was $6.4 billion at Amgen, up from $1.4 billion in the prior quarter.
  • Over the last five years, Shares Repurchased for AMGN hit a ceiling of $10.7 billion in Q1 2018 and a floor of $555.0 million in Q2 2020.
  • Median Shares Repurchased over the past 5 years was $1.4 billion (2021), compared with a mean of $2.4 billion.
  • Biggest five-year swings in Shares Repurchased: soared 1725.43% in 2018 and later tumbled 77.02% in 2020.
  • Amgen's Shares Repurchased stood at $2.1 billion in 2018, then crashed by 48.49% to $1.1 billion in 2019, then grew by 10.15% to $1.2 billion in 2020, then rose by 19.75% to $1.4 billion in 2021, then surged by 340.75% to $6.4 billion in 2022.
  • The last three reported values for Shares Repurchased were $6.4 billion (Q1 2022), $1.4 billion (Q4 2021), and $1.1 billion (Q3 2021) per Business Quant data.